CUSTIRSEN IN COMBINATION WITH DOCETAXEL AND PREDNISONE FOR PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (SYNERGY TRIAL): A PHASE 3, MULTICENTRE, OPEN-LABEL, RANDOMISED TRIAL Article Chi K.N., Gleave M., Higano C.S., Blumenstein B., Ferrero J.M., Reeves J., Feyerabend S., Stenzl A., Gravis G., Merseburger A.S., Bergman A.M., Mukherjee S.D., Zalewski P., Saad F., Jacobs C., De Bono J.S. The Lancet Oncology. Vol. 18. 2017. P. 473-485
SOCIETAL AND POLITICAL WILL FOR CANCER PREVENTION IN RUSSIA Article Jargin S.V. The Lancet Oncology. Vol. 15. 2014.
AFLIBERCEPT VERSUS PLACEBO IN COMBINATION WITH DOCETAXEL AND PREDNISONE FOR TREATMENT OF MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (VENICE): A PHASE 3, DOUBLE-BLIND RANDOMISED TRIAL Article Tannock I.F., Fizazi K., Ivanov S., Thellenberg Karlsson, Flechon A., Skoneczna I., Orlandi F., Gravis G., Matveev V., Bavbek S., Gil T., Viana L., Aren O., Karyakin O., Elliott T., Birtle A., Magherini E., Hatteville L., Petrylak D., Tombal B., Rosenthal M. The Lancet Oncology. Vol. V14. 2013. P. 760-768
RADIOTHERAPY IN RUSSIA: A REDUNDANT METHOD Article Jargin S.V. The Lancet Oncology. Vol. 10. 2009. P. 8-9
PROCEEDINGS OF THE 15TH JOINT WORKSHOP ON ELECTRON CYCLOTRON EMISSION AND ELECTRON CYCLOTRON RESONANCE HEATING, EC-15 Conference proceedings 15th Joint Workshop on Electron Cyclotron Emission, ECE 2008 and Electron Cyclotron Heating, ECH 2008. World Scientific Publishing Co. Pte Ltd.